FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | EvidenceVariable |
| Id | EvidenceVariable-370507.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: EvidenceVariable 370507
version: 23; Last updated: 2025-08-18 13:22:42+0000; Language: en
Profile: VariableDefinition
EvidenceVariableHandlingDetail: Evidence variable handling not specified
ArtifactPublicationStatus: Active
url: https://fevir.net/resources/EvidenceVariable/370507
identifier: FEvIR Object Identifier/370507, FEvIR Linking Identifier/NCT03640312-secondaryOutcome-3-12-weeks-
name: Proportion_of_Patients_With_Hypertension_Control_at_6_and_12_weeks_12_weeks_at_NCT03640312
title: Proportion of Patients With Hypertension Control at 6 and 12 weeks - 12 weeks at (NCT03640312)
citeAs:
Proportion of Patients With Hypertension Control at 6 and 12 weeks - 12 weeks at (NCT03640312) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 370507. Revised 2025-08-18. Available at: https://fevir.net/resources/EvidenceVariable/370507. Computable resource at: https://fevir.net/resources/EvidenceVariable/370507#json.
status: Active
author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
description:
This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
| Reference |
| Group: membership = conceptual; combinationMethod = all-of |
handling: extension
classifier: Outcome Measure, Secondary
Generated Narrative: Group #variable-definition
Profile: ConceptualCohortDefinition
membership: Conceptual
combinationMethod: All of
characteristic
code: defined by Reference
value: Proportion of Patients With Hypertension Control at 6 and 12 weeks (NCT03640312)
exclude: false
Timings
Text 6 and 12 weeks characteristic
code: defined by CodeableConcept
value: 12 weeks
exclude: false
{
"resourceType": "EvidenceVariable",
"id": "370507",
"meta": {
"versionId": "23",
"lastUpdated": "2025-08-18T13:22:42.074Z",
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"
]
},
"language": "en",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"contained": [
{
"resourceType": "Group",
"id": "variable-definition",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-cohort-definition"
]
},
"membership": "conceptual",
"combinationMethod": "all-of",
"characteristic": [
{
"code": {
"text": "defined by Reference"
},
"valueReference": {
"reference": "EvidenceVariable/367886",
"type": "EvidenceVariable",
"identifier": {
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "NCT03640312-secondaryOutcome-3",
"assigner": {
"display": "Computable Publishing LLC"
}
},
"display": "Proportion of Patients With Hypertension Control at 6 and 12 weeks (NCT03640312)"
},
"exclude": false,
"timing": [
{
"text": "6 and 12 weeks"
}
]
},
{
"code": {
"text": "defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "12 weeks"
},
"exclude": false
}
]
}
],
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail",
"valueCodeableConcept": {
"coding": [
{
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "evidence-variable-handling-not-specified",
"display": "Evidence variable handling not specified"
}
]
}
},
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code": "active",
"display": "Active"
}
]
}
}
],
"url": "https://fevir.net/resources/EvidenceVariable/370507",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "370507",
"assigner": {
"display": "Computable Publishing LLC"
}
},
{
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "NCT03640312-secondaryOutcome-3-12-weeks-",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"name": "Proportion_of_Patients_With_Hypertension_Control_at_6_and_12_weeks_12_weeks_at_NCT03640312",
"title": "Proportion of Patients With Hypertension Control at 6 and 12 weeks - 12 weeks at (NCT03640312)",
"citeAs": "Proportion of Patients With Hypertension Control at 6 and 12 weeks - 12 weeks at (NCT03640312) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 370507. Revised 2025-08-18. Available at: https://fevir.net/resources/EvidenceVariable/370507. Computable resource at: https://fevir.net/resources/EvidenceVariable/370507#json.",
"status": "active",
"author": [
{
"name": "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"
}
],
"publisher": "Computable Publishing LLC",
"contact": [
{
"telecom": [
{
"system": "email",
"value": "support@computablepublishing.com"
}
]
}
],
"description": "This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"definition": {
"reference": {
"reference": "#variable-definition",
"type": "Group"
}
},
"handling": "extension",
"classifier": [
{
"text": "Outcome Measure"
},
{
"text": "Secondary"
}
]
}